a standard mercury sphygmomanometer with the participant in the sitting position after at least a 5-min rest. Bodyweight and height were measured in the morning while the subjects were in a fasting state. Body mass index (BMI) was calculated as bodyweight (kg) divided by squared height (m 2 ). Smoking habit, alcohol intake, and duration of sleep were determined by using a self-reported questionnaire. Subjects who had never smoked and ex-smokers were classified as 'non-smokers'. Subjects were divided into 2 groups, that is, one group who had more than 5 h of sleep and the other group who had less than 5 h of sleep.
Outcome Measures
During the follow-up period of 10 years (mean ± SD: 9.5±0.8 years), any sick leave taken by the subjects was immediately reported to the company's health management center. The occurrence of CAD was identified annually between 1995 and 2005 after an examination of all the details of a subject's clinical chart.
CAD was identified as acute myocardial infarction and angina pectoris. The criteria for CAD were modified from World Health Organization Expert Committee. 18 Angina pectoris was defined as repeated episodes of chest pain during effort and usually disappearing rapidly after the cessation of effort or on use of sublingual nitroglycerin. Additionally, subjects with angina pectoris had coronary stenosis of greater than 75% of the luminal diameter by coronary angiography. 19 Acute myocardial infarction was defined by the presence of at least 2 of the following criteria: a history of prolonged discomfort or anginal equivalent, ECG changes consistent with ischemia or necrosis, and elevated cardiac enzymes.
Statistical Analysis
Continuous variables were expressed as mean ± SD; TG was described as a median (and interquartile range) for variables with a skewed distribution, and smoking habit and duration of sleep were described as a percentage. The differences of variables between the 2 groups were examined by using the Student's unpaired t-test for approximately normal distributed variables, or by the Wilcoxon rank-sum test for TG, and by the Fisher's exact test for the proportion of smoking habit and duration of sleep. The Cox proportional hazard model was used to examine the relationship between risk factors and CAD and to access the unadjusted and adjusted hazard ratio (HR) of events. The principle model included candidate variables for age (years), smoking habit (non and current smokers), alcohol consumption (g/day), duration of sleep (less and more than 5 h), BMI, systolic BP (mmHg), TC (mg/dl), HDL-C (mg/dl), log TG, FPG (mg/dl), and UA (mg/dl). Age and BMI were indicated by one additional increase. Systolic BP was indicated by an additional 10 mmHg increase. Both TC and FPG were indicated by an additional 10 mg/dl increase, and HDL-C was indicated by an additional 5 mg/dl increase. TG was calculated as a log-transformed value. A p value less than 0.05 was considered to indicate statistical significance. All statistical analyses were performed by using the SPSS statistical package for Windows version 12.0 (Chicago, IL, USA). 20
Results
During the follow-up period of 10 years, 111 subjects had CAD; 74 subjects had acute myocardial infarction and 37 subjects had angina pectoris. The age at baseline was 46.6±5.2 years (ranging from 33 to 55 years), and that at onset of CAD was 51.6±5.7 years (ranging from 36 to 59 years).
The baseline characteristics of the subjects with and without CAD are shown in Table 1 . Subjects with CAD were more likely smokers and less likely drinkers. They had a greater BMI, systolic BP, TC, TG, and FPG levels, and a lower HDL-C level. There were no significant differences in other variables such as age, duration of sleep and UA between these 2 groups of subjects.
By using the Cox proportional hazard models, smoking habit, systolic BP, TC, TG, FPG and low HDL-C were identified as significant independent risk factors for CAD ( Table 2 ). The HR of CAD adjusting for risk factors with smoking habit was 5.59 (95% confidence interval (CI): 2.85-10.96, p<0.001), with a 10 mmHg increase in systolic BP was 1.01 (95% CI: 1.02-1.25, p<0.05), with a 10 mg/dl increase in TC was 1.14 (95% CI: 1.07-1.21, p<0.001), with a one increase in log TG was 3.07 (95% CI: 1.01-9.35, p<0.05), with a 5 mg/dl increase in HDL-C was 0.80 (95% CI: 0.73-0.89, p<0.001), and with a 10 mg/dl increase in FPG was 1.05 (95% CI: 1.01-1.10, p<0.05). By using the Cox proportional hazard models, TG was identified as a significant independent risk factor for CAD ( Table 3 ). The unadjusted HR of CAD for TG was 23.74 (95% CI: 10.10-55.81, p<0.001). TG was an independent risk factor for CAD even after the adjustment with such unfounding variables such as TC and HDL-C. The adjusted HR of CAD was 3.07 (95% CI: 1.01-9.35, p<0.05).
HRs for CAD were further assessed within the quartile levels of TG ranging ≤78, 79-110, 111-161, and ≥162 mg/dl (Table 4 ). There was a dose-response relationship between TG and the risk of CAD. Comparing the lowest to the second lowest quartile level of TG, the unadjusted HR was 7.22 (95% Cl: 2.15-24.20, p<0.01). After adjusting for TC, HDL-C, and other variables, the adjusted HR of CAD was 4.13 (95% Cl: 1.22-14.00, p<0.05).
HDL-C values in the quartile levels of TG are shown in Fig 1. There was a negative relationship between the quartile levels of TG and HDL-C values. The quartile levels of TG from the lowest to highest had HDL-C values (mean ± SD) of 63.8±17.6, 55.6±14.8, 50.1±13.5, and 43.8±11.6 mg/dl, respectively.
HRs for CAD were further assessed by the combination of TG and HDL-C levels ( Table 5 ). We divided these into 3 groups: the low TG and high HDL-C (group 1), the high TG and high HDL-C (group 2), and the high TG and low HDL-C (group 3). If group 1 was considered to be a reference, the adjusted HR of CAD in group 2 and 3 was 5.52 (95% CI: 1.71-17.85, p<0.01) and 12.59 (95% CI: 3.82-41.46, p<0.001), respectively. TG level was divided into a high or low group, which was more or less than 78 mg/dl. HDL-C level was divided into a high or low group, which was more or less than 40 mg/dl. p<0.05 is considered to be significant. HR, hazard ratio; CI, confidence interval; TG, triglyceride; HDL-C, highdensity lipoprotein cholesterol. 
Discussion
The present study indicated that fasting TG is significantly associated with the development of CAD in middle-aged Japanese men. A serum TG concentration level greater than 78 mg/dl is a significant risk for CAD. To our knowledge, this is the first epidemiological study to demonstrate a significant relationship between fasting TG and CAD among Japanese men.
The relationship between dyslipidemia and CAD risk has been well established. 3, 21, 22 Previous studies have demonstrated that high TC increases the risk for CAD and a 1% reduction in serum TC concentration reduces CAD risk by 2%. 1 The present study has shown that a 10 mg/dl increase in TC increases CAD risk by 14%. Even though hyperlipidemia is an established risk factor for CAD, approximately 40% of CAD patients had a TC level below the normal range, and most of these patients had low levels of HDL-C, regardless of the TG levels. 23 Recently, the International Diabetes Federation showed that other lipoproteins such as HDL-C and TG could be the potential therapeutic targets. 24 Low levels of HDL-C is a well-established risk factor for the development of CAD. Previous studies demonstrated that a 1% increase in HDL-C is associated with a 2-3% reduction in the risk of CAD. 5 The present study similarly demonstrated that a decreased of CAD risk was 20% by a 5 mg/dl increase of HDL-C.
Previous studies have reported inconsistent results regarding the association between TG and CAD. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] The Copenhagen Male Study, which followed 2,906 white men over 8 years, found that fasting TG was independently associated with the incidence of CAD. However, when adjusted for HDL-C and low-density lipoprotein (LDL) cholesterol levels, TG did not increase the risk for CAD. 9 In most studies, the relationship between TG and CAD risk is not statistically significant, especially in men. 9, 25 The present study demonstrated that fasting TG has a dosedependent relationship with the development of CAD, with adjusting for HDL-C, TC and other risk factors. A previous study demonstrated a close correlation of remnant-like particle (RLP)-cholesterol levels with TG levels in the Japanese population. 26 RLP-cholesterol contributed to atherogenesis by directly affecting the vascular, endothelial and smooth muscle cells. 27 This is because fasting TG might be an independent risk factor for CAD in our population.
Additionally, the analysis of quartile levels of TG indicated that TG greater than 78 mg/dl was a significant risk for causing CAD. By comparing 2 groups that are greater or less than 78 mg/dl, the adjusted HR of CAD was 4.18 (95% Cl: 1.35-14.24, p=0.014) (data not shown) and the same result was indicated.
Both TG and HDL-C are inversely correlated and mechanistically linked means of lipid transfer activities. 28 In our population, the increase of serum TG concentration affected the decrease of serum HDL-C concentration. These results demonstrated that subjects who had higher levels of TG could have another risk factor such as low HDL-C, which might have more risk for CAD occurrence. The present study demonstrated that subjects who had a high TG level and a low HDL-C level had a significantly higher risk of having CAD than those who had a high TG level and a normal HDL-C level.
Hypertriglycemia is associated with increased concentrations of factor VII and plasminogen activator inhibitor, which may accelerate thrombotic processes. 29 Hyperglyc-emia is also closely associated with small, dense LDL, which has increased entry into and retention in the arterial wall because of a low affinity for LDL receptors and susceptibility to oxidation; this is considered to be more atherogenic than larger LDL particles. [29] [30] [31] [32] [33] However, it is difficult to assess LDL particle size directly. These results have indicated that the measurement of TG is considered to be important to predict the risk for the development of CAD.
Study Limitations
The present study subjects included only males who were aged between 33 and 55 years. Therefore, we need to be cautious to extend the present study results to the general population. Recently, metabolic syndrome was a significant risk factor for the development of CAD, and abdominal obesity and insulin resistance were crucial problems. These risk factors were not investigated in the present study and further examinations using these variables were required. However, the present study design enables us to enrol and perform the long-term follow-up studies in many subjects.
In conclusion, the present study demonstrated that fasting TG is an independent risk factor for CAD among middle-aged Japanese men.
